Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Takeda Pharmaceutical ADR Rep 0.5 Ord Shs V.TAK


Primary Symbol: TAK

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.


NYSE:TAK - Post by User

Post by Bedilgenton Sep 01, 2013 7:20am
414 Views
Post# 21712158

Krutec TAK management and exploration team

Krutec TAK management and exploration teamI just took a quick look at the latest Sedar filing for TAK. I know there is some work being done by Sean Ryan and his crew on Rosebute, but I do not know if they will drill or not. I can tell you one thing that has not changed with Zack Dingsdale and Mark Fekete and that is that they continue to pay themselves. Consulting fees-$30,000, $45,000 in management fees to Zach, $45,000 in mineral consulting exploration fees to the V-P of Exploration- Mark Fekete, $30,000 in professional fees to the CFO, $31,500 in rent to a private company controlled by 2 directors of the company. These guys have to stop paying themselves right now. There is now $954,000 and change in cash and these guyd have not even drilled anything yet. Time to button dwon the hatches boys. You can only blame market conditions so long. I don't even want to go over and look at Stakeholder Gold and Hinterland ( Mark Fekete companies) as I am sure the management of those companies continue to get paid as well. 
Bullboard Posts